mRCC Patient Resource: Adverse Events Management with Treatment Diary
mRCC Patient Resource: Adverse Events Management with Treatment Diary
8 PRINTABLE VERSIONS AVAILABLE.
CUA Members: Log in to access printable versions and to download the tools directly to your preferred device.
- Cabozantinib AE management & patient diary
- Nivolumab & Cabozantinib AE management & patient diary
- Nivolumab & Ipilimumab AE management & patient diary
- Pazopanib AE management & patient diary
- Pembrolizumab AE management & patient diary
- Pembrolizumab & Axitinib AE management & patient diary
- Pembrolizumab & Lenvatinib AE management & patient diary
- Sunitinib AE management & patient diary
- Cabozantinib AE management & patient diary
- Nivolumab & Cabozantinib AE management & patient diary
- Pazopanib AE management & patient diary
- Pembrolizumab AE management & patient diary
- Pembrolizumab & Axitinib AE management & patient diary
- Pembrolizumab & Lenvatinib AE management & patient diary
- Sunitinib AE management & patient diary
All CUA educational materials have undergone an official approval process and are the intellectual property of the Canadian Urological Association (CUA). Reproduction of these documents in any form requires the express written consent of the CUA. For any permission requests, comments/feedback, or to enquire about program content, please contact: rita.demarco@cua.org.
